
Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe.
To fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.
Its three companies - bioMérieux, Transgene, Silliker - have made major advances in the fight against infectious diseases and cancers, as well as in the field of nutrition and food safety.
Institut Mérieux employs close to 10,000 people in the service of global
public health. It is present in over 40 countries, and generates sales of over €1.3 billion.